SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001613377-14-000001
Filing Date
2014-07-11
Accepted
2014-07-11 13:35:39
Documents
1
Period of Report
2014-07-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1467
  Complete submission text file 0001613377-14-000001.txt   2869
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 924 EDGEMOOR ROAD CHERRY HILL NJ 08034
Business Address
Pascale Adam (Reporting) CIK: 0001613377 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27072 | Film No.: 14971305